Replies to post #25695 on Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

The strangest thing is living..LC Sentinel Test belongs to Provista Diagnostics according to Provista Dx and William Gartner..It was part of William's and the Angel Investors negotiation..William kept Lympro Test and the new Provista Diagnostics kept the Breast and Lung Cancer Tests.. All documented...You can take that to the bank. No opinion needed...Just the facts..Wolf

William is currently VP of Development for Provista Diagnostics..He cannot use DR-70..It is in the hands of Provista DX not GCDX..The other part of the puzzle is william does not have free will to the LC Sentinel test, therefore William would need both tests in order to go on his own...


livinginsv Monday, 10/20/14 04:14:34 PM
Re: guardiangel post# 25694
Post # of 25695
times change, LCs was gartner's idea, still is . . . but it's under the corporate entity of GCDx, and the reagents are free to use . . . how could WG run a VS without the reagents? . . . the story must seem to sour when there is no payday for RXPC involved . . .

[GetSeriousOK]

GCDx should just call it "LC Sentinel."

Provista wouldn't mind. Radient, of course, has no say in the matter.

Here's what GCDx says about their LC test on Fundable:

https://www.fundable.com/the-lung-cancer-test

"Utilizing these proprietary cancer biomarkers, coupled with a mathematical algorithm, The Lung Cancer Test can detect the presence of lung cancer in high-risk populations with a sensitivity of 87% and a specificity of 95%. The overall accuracy of the test is 97%, defined by the area under the receiver-operating characteristic (ROC) curve."

Here's what Provista said about LC Sentinel in 2010:

"The data generated in this final study proved consistent with previous findings and produced positive clinical performance marks of 87% sensitivity; 95% specificity; and an ROC Accuracy of 0.97. "

http://www.marketwired.com/press-release/radient-pharmaceuticals-provista-life-sciences-announce-new-blood-test-lung-cancer-nyse-amex-rpc-1334094.htm

Could this be any more obvious?